NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9%
Mon, 17 Feb

NOVARTIS has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

NOVARTIS Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m1,3561,1781,175-0.3%-13.4%
Other incomeRs m11510073-27.1%-36.4%
TurnoverRs m1,4711,2781,248-2.4%-15.2%
ExpensesRs m1,2211,2061,085-10.1%-11.2%
Gross profitRs m135-2890-33.3%
DepreciationRs m1031334.1%244.2%
InterestRs m01717-1.2%5433.3%
Profit before taxRs m24024114374.2%-52.6%
TaxRs m1117637-52.1%-67.2%
Profit after taxRs m129-5277-39.9%
Gross profit margin%10.0-2.47.7
Effective tax rate%46.4317.532.1
Net profit margin%8.7-4.16.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 13.4% on a year-on-year (YoY) basis. The expenses were down by 11.2% YoY during the same period.
  • The company's operating profit declined by 33.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.7% in 3QFY20 as against 10.0% in 3QFY19.
  • Depreciation charges increased by 244.2% and finance costs increased by 5433.3% YoY, respectively.
  • Other income declined by 36.4% YoY during the quarter.
  • Net profit for the quarter declined by 39.9% YoY. Net profit margins during the quarter declined from 8.7% in 3QFY19 to 6.2% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.3% on a quarter-on-quarter (QoQ) basis. The expenses were down by 10.1% QoQ during the same period.
  • The company's operating profit declined by 422.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 7.7% in 3QFY20 as against 2.4% in 2QFY19.
  • Net profit for the quarter increased by 248.1% QoQ, while net profit margins increased from -4.1% in 2QFY19 to 6.2% in 3QFY20.

To see how NOVARTIS has performed over the last eight quarters,please visit here.

EXPLORE: Here's How You Can Get 1 YEAR of Our Proven Smallcap Service for FREE...

NOVARTIS Share Price Performance

Over the last one year,NOVARTIS share price has moved down from Rs 652.1 to Rs 638.5, registering a Loss of Rs 13.7 or around 2.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,304.8 (down 0.8%). Over the last one year it has moved up from 13,433.0 to 14,304.8, a gain of 872 points (up 6.5%).

Overall, the S&P BSE SENSEX is up 14.9% over the year.

Current Valuations

At the current price of Rs 638.5, the price to earnings (P/E) ratio of NOVARTIS stands at 938.1 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 28.2 times.

Equitymaster requests your view! Post a comment on "NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9%". Click here!

  

Related Views on News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

3 Stocks to Ride the Big Rebound in Smallcaps(Profit Hunter)

Aug 11, 2020

The rebound ratio suggests that smallcaps are set for big gains but this time it will be limited to a few stocks. Make sure you choose wisely.

Governance: for the country and your portfolio.(The Honest Truth)

Aug 14, 2020

Ajit Dayal on the need of socially responsible governance.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 14, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS